Immunome Ownership | Who Owns Immunome?
Immunome Ownership Summary
Immunome is owned by 79.73% institutional investors, 16.81% insiders, and 3.47% retail investors. Fmr is the largest institutional shareholder, holding 40.85% of IMNM shares. T. Rowe Price US Small-Cap Core Equity is the top mutual fund, with 3.45% of its assets in Immunome shares.
IMNM Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immunome | 79.73% | 16.81% | 3.47% |
| Sector | Healthcare Stocks | 47.06% | 8.01% | 44.93% |
| Industry | Biotech Stocks | 44.97% | 7.82% | 47.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.21M | 40.85% | $50.95M |
| Blackrock | 3.76M | 36.46% | $45.48M |
| Vanguard group | 2.92M | 28.34% | $35.35M |
| State street | 2.36M | 22.93% | $28.61M |
| Price t rowe associates inc /md/ | 2.02M | 19.61% | $24.46M |
| Geode capital management | 1.06M | 10.31% | $12.86M |
| Redmile group | 4.89M | 8.16% | $59.16M |
| Ecor1 capital | 3.88M | 6.47% | $46.94M |
| T. rowe price investment management | 3.88M | 6.47% | $46.93M |
| Janus henderson group | 3.16M | 5.28% | $38.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 4.89M | 3.58% | $59.16M |
| Opaleye management | 1.10M | 3.05% | $13.34M |
| Ecor1 capital | 3.88M | 1.44% | $46.94M |
| Tang capital management | 720.00K | 0.89% | $8.71M |
| Avidity partners management lp | 873.89K | 0.45% | $10.57M |
| Sofinnova investments | 655.68K | 0.41% | $7.93M |
| Prosight management, lp | 65.00K | 0.24% | $786.50K |
| Vista private wealth partners. | 39.12K | 0.19% | $473.30K |
| Emfo | 11.84K | 0.13% | $143.20K |
| Titleist asset management | 63.97K | 0.12% | $774.00K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.76M | 0.00% | 2.93M |
| T. rowe price investment management | 3.88M | 0.03% | 2.36M |
| State street | 2.36M | 0.00% | 2.16M |
| Janus henderson group | 3.16M | 0.02% | 1.63M |
| Marshall wace, llp | 1.71M | 0.03% | 1.19M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 385.07K | 0.01% | -1.26M |
| Vestal point capital, lp | - | - | -1.00M |
| Invesco | 25.94K | 0.00% | -599.15K |
| Farallon capital management | - | - | -594.00K |
| Millennium management | - | - | -465.29K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Opaleye management | 1.10M | 3.05% | 1.10M | $13.34M |
| Nuveen asset management | 299.29K | 0.00% | 299.29K | $3.62M |
| Adage capital partners gp | 220.00K | 0.00% | 220.00K | $2.66M |
| Axa | 179.69K | 0.01% | 179.69K | $2.17M |
| Rafferty asset management | 116.05K | 0.01% | 116.05K | $1.40M |
Sold Out
| Holder | Change |
|---|---|
| Federated hermes | -335.00 |
| Pacer advisors | -660.00 |
| Kbc group nv | -1.01K |
| Simplex trading | -3.17K |
| Macquarie group | -3.52K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2024 | 115 | 7.48% | 47,785,575 | 30.06% | 79 | 2.12% | 76 | -12.64% | 22 | 83.33% |
| Mar 31, 2024 | 107 | 81.36% | 36,741,102 | 70.98% | 61 | 4.77% | 87 | 107.14% | 12 | 100.00% |
| Dec 31, 2023 | 59 | 55.26% | 21,488,187 | 810.23% | 35 | 231.10% | 42 | 180.00% | 6 | -40.00% |
| Sep 30, 2023 | 38 | -5.00% | 2,360,732 | 21.26% | 3 | 37.33% | 15 | - | 10 | 42.86% |
| Jun 30, 2023 | 40 | 25.00% | 1,946,809 | 4.79% | 3 | 33.81% | 15 | 66.67% | 7 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price US Small-Cap Core Equity | 2.07M | 3.45% | 792.36K |
| T. Rowe Price Small-Cap Stock | 2.07M | 3.45% | 129.20K |
| Fidelity Growth Compy Commingled Pl O | 1.79M | 2.97% | - |
| Fidelity Growth Compy Commingled Pl S | 1.80M | 2.88% | 10.54K |
| Vanguard Total Stock Mkt Idx Inv | 1.64M | 2.63% | 2.26K |
| T. Rowe Price Health Sciences | 1.53M | 2.54% | 127.28K |
| iShares Russell 2000 ETF | 1.34M | 2.14% | -3.00K |
| Fidelity Growth Company Fund | 1.26M | 2.02% | -2.67K |
| T. Rowe Price Instl Small-Cap Stock | 1.03M | 1.71% | 68.50K |
| T. Rowe Price U.S. SC Core Eq Tr-Z | 1.03M | 1.71% | 455.51K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 19, 2024 | Rosett Max | Chief Financial Officer | Sell | $230.22K |
| Aug 16, 2024 | BIENAIME JEAN JACQUES | - | Buy | $97.61K |
| Aug 15, 2024 | Higgins Jack | Chief Scientific Officer | Sell | $49.07K |
| May 21, 2024 | BIENAIME JEAN JACQUES | - | Buy | $27.14K |
| May 21, 2024 | SIEGALL CLAY B | President and CEO | Buy | $281.55K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q3 | 1 | 2 |
| 2024 Q2 | 3 | - |
| 2024 Q1 | - | - |
| 2023 Q4 | 2 | - |
| 2023 Q2 | - | - |
IMNM Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools